Geneos Wealth Management Inc. Boosts Stock Position in MetLife, Inc. (NYSE:MET)

Geneos Wealth Management Inc. raised its stake in MetLife, Inc. (NYSE:METFree Report) by 5.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,227 shares of the financial services provider’s stock after purchasing an additional 176 shares during the quarter. Geneos Wealth Management Inc.’s holdings in MetLife were worth $264,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. MeadowBrook Investment Advisors LLC increased its stake in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its holdings in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its position in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the period. Peterson Financial Group Inc. purchased a new stake in MetLife in the 3rd quarter valued at approximately $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of MetLife during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Trading Up 1.3 %

MetLife stock opened at $86.77 on Thursday. The stock has a market cap of $60.08 billion, a PE ratio of 17.49, a P/E/G ratio of 0.65 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a 50-day moving average price of $83.95 and a 200 day moving average price of $80.30. MetLife, Inc. has a 52 week low of $64.61 and a 52 week high of $89.05.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.51%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is 43.95%.

Analyst Ratings Changes

MET has been the subject of several recent analyst reports. Barclays raised their price target on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, January 6th. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. TD Cowen upped their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Finally, BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target for the company. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $90.46.

Read Our Latest Research Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.